University of Missouri School of Medicine MU Health School of Medicine
News Divider
            


World Ophthalmology Congress Brings MU Discoveries Into Focus


Nanomedicine research could help millions suffering from corneal conditions

Mohan
Rajiv Mohan, PhD
A University of Missouri research program that examines how nanotechnology could treat corneal diseases will be featured at the 2010 World Ophthalmology Congress from June 5 to June 9, 2010. Rajiv Mohan, PhD, associate professor of ophthalmology at the MU School of Medicine, will present how nanoparticles could be paired with therapeutic genes to deliver new treatments to corneal tissue. The promising new therapy could help millions who suffer from corneal scarring, wounds and other conditions.

Mohan was one of only five basic scientists invited to make a presentation at the nanotechnology session of the meeting, which will draw more than 6,000 attendees to Berlin.

"Because the meeting is primarily for physicians to discuss clinical care, basic science research that is presented must be able to translate from the bench to the bedside," Mohan said. "This selection is a direct reflection of MU's commitment to translational research in ophthalmology and to discoveries campuswide."

The cornea is the dome-shaped surface that functions as the eye's outermost layer. It is the first line of defense in shielding the eye from injury as well as infections. Corneal haze, scarring and abnormal blood vessel development are among the leading causes of vision impairment in the world and affect approximately 1.5 million Americans every year. Abnormal wound healing due to corneal injury or infection has been shown to play a critical role in causing these and other corneal disorders and diseases.

Mohan's laboratory is researching how hybrid gold nanoparticles and biodegradable polymeric nanoparticles can be used as a nonviral carrier to deliver gene therapy to the cornea. The nanoparticle-based gene therapy has shown minimal side effects in preclinical studies.

"The current nonviral vectors, or gene delivery vehicles, are incapable of delivering therapeutic levels of genes into the cells of the cornea," Mohan said. "Nanoparticles, because they are smaller, could provide a less invasive option for delivering the gene therapy effectively while reducing the risk of infection and side effects from treatment."

Mohan's corneal gene therapy research is funded by more than $2.8 million in grants from the National Eye Institute and Department of Veterans Affairs. The Association for Research in Vision and Ophthalmology recently identified findings from his laboratory as among the "the newest and most innovative" in the field of nanotechnology for drug and gene delivery.

The World Ophthalmology Congress brings together ophthalmologists to enhance education and improve access to the highest quality eye care. More information about its efforts to preserve and restore vision is available at http://www.icoph.org/advancing_leadership/ico_commitments_programs.html


MU Health Magazine

Divider

News and Events

David Chang Grill with Caution
Wire bristles from barbecue brushes can cause serious injuries
Tahir Rahman Extreme Beliefs Often Mistaken for Insanity, New Study Finds
Researchers say new term offers more precise definition of non-psychotic behaviors
Paul Tatum Family Medicine Professor Wins Distinguished Physician Award
Tatum recognized for outstanding care of patients near the end of life
Seth Sherman Minimally Invasive Tendon Repair Technique Supports Knee Movement Sooner after Surgery
Researchers found suture anchors, a less-invasive repair technique, responded better to strength-testing after surgery
2016 Graduation MU School of Medicine Awards 86 Medical Degrees at Commencement Ceremony
The graduates will go on to receive additional training as resident physicians in their chosen specialties
Patrice Delafontaine MU School of Medicine Dean Inducted into Prestigious Medical Society
Delafontaine joins elite group of physicians in American Clinical and Climatological Association
Steven Zweig MU Family Medicine Ranked Among Nation’s Best by U.S. News & World Report
Department has been in top 10 for 23 consecutive years
Uzma Khan MU Initiative Helps Rural Doctors Treat Chronic Pain
Show-Me ECHO to offer special training session April 28
Legacy Teachers MU School of Medicine Program Expands to Other Medical Schools
MU’s Legacy Teachers program lets students recognize patients as educators
Susan Nagel Oil and Gas Wastewater Disposal May Increase Endocrine Disrupting Activity
Scientists draw conclusions after study at natural gas and oil extraction wastewater disposal facility
St. Baldricks 2016 Participants Go Bald for Childhood Cancer Research
Community donates more than $40,000 to the cause



Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323

Diamond Dixon
DixonDi@health.missouri.edu
(573) 884-7541

Justin Kelley (Photographer)
kelleyju@health.missouri.edu
(573) 882-5786
Pager (573) 397-9289


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Jennifer Orford
orfordj@health.missouri.edu
(573) 882-0298

Jesslyn Chew
chewj@missouri.edu
(573) 884-2891

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115

Justin Willett
willettj@health.missouri.edu
(573) 884-7740



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.